PAXAFE’s Mark Talens Sees AI Agents Ending the Dashboard Era

Mark Talens, chief commercial officer at PAXAFE, says pharma companies now have the ability to look at their supply chains across functions, not just one function at a time. Asked by Pharmaceutical Commerce at LogiPharma USA 2026 where end-to-end visibility will take the industry, Talens, who joined a keynote panel on the topic, says companies can look past planning, logistics and quality operations individually. Instead, they can see the supply chain by business line or product line and control their whole end-to-end value chain. He calls it a “dream statement.”

About two and a half years ago, Talens says, he thought decision intelligence delivered through a large language model (LLM) was still a long way off. “Well, wake up. It’s here,” he says, adding that development cycles keep getting faster. He says there is now an LLM that doesn’t hallucinate because it is fully guard-railed, so it can be used in a pharma environment, and it should be put to work creating a horizontal value chain. In another part of the interview, Talens cautioned that visibility data needs context before AI is layered on top.

His second point is that standard analytics and dashboards will never be exactly what a user wants at the right moment. Instead, Talens describes asking an agent that sits across a company’s validated environment questions such as which lanes are at risk, where things are starting to matter more for the patient and what the average release time is. When managers, customers or regulators start asking questions, the answers are at their fingertips, with no need to look at or develop dashboards.

“I think dashboards are done for, if I’m going to be honest,” Talens says, adding that this is becoming part of day-to-day operations.

Watch the previous installments of Talens’ interview:

1. Supply Chain Visibility Needs Context Before AI, Says PAXAFE’s Mark Talens
2. PAXAFE’s Mark Talens: Supply Chain Teams Must Shift From Firefighters to Orchestrators